| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthesiology | 22 | 2023 | 27 | 6.910 |
Why?
|
| Pain, Postoperative | 39 | 2023 | 305 | 6.390 |
Why?
|
| Analgesics, Opioid | 35 | 2022 | 222 | 5.820 |
Why?
|
| Analgesia, Obstetrical | 24 | 2023 | 27 | 5.530 |
Why?
|
| Nerve Block | 18 | 2020 | 64 | 5.140 |
Why?
|
| Analgesia, Epidural | 27 | 2023 | 54 | 4.870 |
Why?
|
| Anesthetics, Local | 28 | 2023 | 77 | 4.780 |
Why?
|
| Internship and Residency | 15 | 2023 | 199 | 3.420 |
Why?
|
| Ambulatory Surgical Procedures | 10 | 2018 | 69 | 3.140 |
Why?
|
| Female | 174 | 2023 | 14048 | 3.090 |
Why?
|
| Dog Diseases | 17 | 2020 | 17 | 2.980 |
Why?
|
| Humans | 205 | 2023 | 24703 | 2.870 |
Why?
|
| Sciatic Nerve | 10 | 2015 | 25 | 2.610 |
Why?
|
| Adult | 106 | 2020 | 7255 | 2.570 |
Why?
|
| Morphine | 13 | 2021 | 71 | 2.420 |
Why?
|
| Pregnancy | 47 | 2023 | 315 | 2.290 |
Why?
|
| Bupivacaine | 17 | 2020 | 45 | 2.230 |
Why?
|
| Laparoscopy | 11 | 2020 | 143 | 2.230 |
Why?
|
| Pain Measurement | 25 | 2020 | 467 | 2.150 |
Why?
|
| Double-Blind Method | 30 | 2020 | 367 | 2.040 |
Why?
|
| Middle Aged | 87 | 2020 | 8294 | 2.010 |
Why?
|
| Prospective Studies | 53 | 2021 | 1612 | 1.990 |
Why?
|
| Randomized Controlled Trials as Topic | 11 | 2015 | 250 | 1.940 |
Why?
|
| Anesthesia | 9 | 2015 | 28 | 1.870 |
Why?
|
| Dexamethasone | 8 | 2015 | 33 | 1.850 |
Why?
|
| Gynecologic Surgical Procedures | 6 | 2017 | 11 | 1.830 |
Why?
|
| Postoperative Complications | 22 | 2022 | 864 | 1.770 |
Why?
|
| Labor, Obstetric | 8 | 2023 | 8 | 1.760 |
Why?
|
| Anesthetics, Inhalation | 5 | 2017 | 12 | 1.750 |
Why?
|
| Dogs | 32 | 2022 | 147 | 1.680 |
Why?
|
| Male | 102 | 2022 | 13669 | 1.630 |
Why?
|
| Lidocaine | 6 | 2017 | 22 | 1.630 |
Why?
|
| Anesthesia, General | 11 | 2017 | 23 | 1.590 |
Why?
|
| Anesthetics, Intravenous | 7 | 2017 | 9 | 1.560 |
Why?
|
| Treatment Outcome | 43 | 2022 | 3208 | 1.530 |
Why?
|
| Opioid-Related Disorders | 3 | 2021 | 58 | 1.490 |
Why?
|
| Chronic Pain | 9 | 2023 | 129 | 1.480 |
Why?
|
| Cesarean Section | 13 | 2018 | 29 | 1.480 |
Why?
|
| Anesthesia, Epidural | 7 | 2018 | 19 | 1.470 |
Why?
|
| Antiemetics | 4 | 2020 | 10 | 1.470 |
Why?
|
| Cats | 6 | 2020 | 28 | 1.460 |
Why?
|
| Ultrasonography, Interventional | 4 | 2019 | 61 | 1.430 |
Why?
|
| Retrospective Studies | 45 | 2022 | 3156 | 1.420 |
Why?
|
| Delivery, Obstetric | 7 | 2017 | 10 | 1.400 |
Why?
|
| Laryngeal Masks | 3 | 2017 | 5 | 1.390 |
Why?
|
| Propofol | 6 | 2017 | 8 | 1.380 |
Why?
|
| Fentanyl | 18 | 2023 | 24 | 1.370 |
Why?
|
| Perioperative Care | 5 | 2015 | 41 | 1.350 |
Why?
|
| Arthroplasty, Replacement, Knee | 5 | 2021 | 609 | 1.320 |
Why?
|
| Amides | 3 | 2016 | 15 | 1.320 |
Why?
|
| Time Factors | 37 | 2019 | 1327 | 1.310 |
Why?
|
| Postoperative Nausea and Vomiting | 9 | 2018 | 16 | 1.250 |
Why?
|
| Labor Pain | 5 | 2023 | 5 | 1.240 |
Why?
|
| Methyl Ethers | 4 | 2017 | 6 | 1.240 |
Why?
|
| Isoflurane | 5 | 2013 | 6 | 1.230 |
Why?
|
| Anesthesia, Obstetrical | 7 | 2018 | 10 | 1.220 |
Why?
|
| Injections, Spinal | 15 | 2020 | 35 | 1.190 |
Why?
|
| Pain Management | 8 | 2020 | 140 | 1.180 |
Why?
|
| Animals | 56 | 2022 | 3330 | 1.170 |
Why?
|
| Post-Dural Puncture Headache | 2 | 2020 | 3 | 1.150 |
Why?
|
| Clinical Competence | 5 | 2013 | 198 | 1.100 |
Why?
|
| Aged | 52 | 2020 | 8382 | 1.090 |
Why?
|
| Burnout, Professional | 3 | 2013 | 23 | 1.090 |
Why?
|
| Bariatric Surgery | 3 | 2020 | 51 | 1.090 |
Why?
|
| Analgesics | 8 | 2022 | 79 | 1.060 |
Why?
|
| Surveys and Questionnaires | 18 | 2023 | 1042 | 1.060 |
Why?
|
| Epinephrine | 5 | 2016 | 31 | 1.040 |
Why?
|
| Acetaminophen | 4 | 2017 | 22 | 1.040 |
Why?
|
| Hysteroscopy | 3 | 2018 | 3 | 1.040 |
Why?
|
| Analgesics, Non-Narcotic | 3 | 2017 | 17 | 1.030 |
Why?
|
| Hysterectomy | 4 | 2020 | 22 | 1.010 |
Why?
|
| Ketamine | 5 | 2015 | 23 | 1.010 |
Why?
|
| Cat Diseases | 3 | 2020 | 4 | 1.000 |
Why?
|
| Mastectomy, Segmental | 2 | 2017 | 29 | 0.970 |
Why?
|
| Intraoperative Complications | 8 | 2022 | 65 | 0.970 |
Why?
|
| Ganglia, Spinal | 2 | 2022 | 58 | 0.960 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2020 | 1026 | 0.950 |
Why?
|
| Population Control | 3 | 2013 | 3 | 0.940 |
Why?
|
| Complex Regional Pain Syndromes | 2 | 2022 | 20 | 0.940 |
Why?
|
| Magnesium | 4 | 2013 | 34 | 0.940 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2022 | 11 | 0.940 |
Why?
|
| Hypnotics and Sedatives | 3 | 2015 | 20 | 0.940 |
Why?
|
| Blood Coagulation Factors | 3 | 2021 | 19 | 0.880 |
Why?
|
| Organization and Administration | 2 | 2015 | 2 | 0.870 |
Why?
|
| Anesthesia Recovery Period | 5 | 2017 | 5 | 0.860 |
Why?
|
| Erythrocyte Transfusion | 4 | 2018 | 12 | 0.820 |
Why?
|
| Electroencephalography | 3 | 2011 | 79 | 0.820 |
Why?
|
| Patient Safety | 2 | 2015 | 31 | 0.820 |
Why?
|
| Pre-Exposure Prophylaxis | 2 | 2020 | 4 | 0.810 |
Why?
|
| Computer Simulation | 3 | 2013 | 174 | 0.800 |
Why?
|
| Spinal Cord Stimulation | 1 | 2022 | 13 | 0.790 |
Why?
|
| Anesthetics | 8 | 2020 | 23 | 0.790 |
Why?
|
| Hypoventilation | 2 | 2014 | 38 | 0.780 |
Why?
|
| Drug Delivery Systems | 2 | 2019 | 25 | 0.780 |
Why?
|
| Postpartum Hemorrhage | 4 | 2016 | 5 | 0.780 |
Why?
|
| Hemorrhage | 6 | 2021 | 66 | 0.770 |
Why?
|
| Abdominal Muscles | 2 | 2020 | 5 | 0.760 |
Why?
|
| Anesthesia, Spinal | 10 | 2018 | 15 | 0.760 |
Why?
|
| Anesthesia, Local | 3 | 2011 | 6 | 0.750 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2020 | 36 | 0.750 |
Why?
|
| Intubation, Intratracheal | 5 | 2013 | 87 | 0.750 |
Why?
|
| Models, Biological | 2 | 2013 | 284 | 0.740 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2015 | 151 | 0.740 |
Why?
|
| Kidney Neoplasms | 2 | 2020 | 63 | 0.730 |
Why?
|
| Elective Surgical Procedures | 3 | 2018 | 34 | 0.720 |
Why?
|
| Osteoarthritis, Knee | 3 | 2021 | 361 | 0.720 |
Why?
|
| Hospitals, Maternity | 2 | 2018 | 3 | 0.710 |
Why?
|
| Dose-Response Relationship, Drug | 17 | 2017 | 314 | 0.710 |
Why?
|
| Femoral Nerve | 2 | 2012 | 9 | 0.700 |
Why?
|
| Reproducibility of Results | 16 | 2019 | 598 | 0.690 |
Why?
|
| Ovarian Neoplasms | 2 | 2011 | 76 | 0.680 |
Why?
|
| Incidence | 12 | 2017 | 697 | 0.670 |
Why?
|
| Adjuvants, Anesthesia | 3 | 2015 | 5 | 0.670 |
Why?
|
| Health Literacy | 3 | 2018 | 102 | 0.670 |
Why?
|
| Larynx | 3 | 2017 | 10 | 0.660 |
Why?
|
| Intraoperative Care | 5 | 2017 | 38 | 0.660 |
Why?
|
| Patients | 3 | 2018 | 31 | 0.650 |
Why?
|
| Pain | 6 | 2022 | 382 | 0.650 |
Why?
|
| Recovery of Function | 4 | 2014 | 292 | 0.650 |
Why?
|
| Propanolamines | 2 | 2018 | 7 | 0.620 |
Why?
|
| Blood Transfusion, Autologous | 2 | 2018 | 2 | 0.620 |
Why?
|
| Patient Satisfaction | 4 | 2018 | 304 | 0.620 |
Why?
|
| Body Mass Index | 5 | 2020 | 421 | 0.610 |
Why?
|
| Operative Blood Salvage | 1 | 2018 | 1 | 0.600 |
Why?
|
| Anesthesia, Conduction | 3 | 2022 | 32 | 0.590 |
Why?
|
| Faculty, Medical | 2 | 2019 | 43 | 0.580 |
Why?
|
| Cross-Sectional Studies | 10 | 2023 | 807 | 0.580 |
Why?
|
| Electric Stimulation | 4 | 2013 | 45 | 0.580 |
Why?
|
| United States | 13 | 2023 | 1873 | 0.580 |
Why?
|
| Journal Impact Factor | 2 | 2015 | 15 | 0.570 |
Why?
|
| Blood Patch, Epidural | 4 | 2020 | 7 | 0.570 |
Why?
|
| Monitoring, Intraoperative | 3 | 2015 | 31 | 0.560 |
Why?
|
| Fetal Death | 1 | 2017 | 3 | 0.550 |
Why?
|
| Perineum | 1 | 2017 | 5 | 0.550 |
Why?
|
| Pharynx | 1 | 2017 | 11 | 0.550 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 192 | 0.540 |
Why?
|
| Lacerations | 1 | 2017 | 16 | 0.540 |
Why?
|
| Patient Positioning | 1 | 2017 | 34 | 0.540 |
Why?
|
| Blood Transfusion | 6 | 2016 | 61 | 0.540 |
Why?
|
| Decision Making | 1 | 2018 | 211 | 0.520 |
Why?
|
| Mothers | 1 | 2018 | 160 | 0.520 |
Why?
|
| Cardiopulmonary Bypass | 10 | 2011 | 12 | 0.510 |
Why?
|
| Coronary Artery Bypass | 6 | 2012 | 17 | 0.510 |
Why?
|
| Placenta Accreta | 1 | 2016 | 1 | 0.510 |
Why?
|
| Prenatal Diagnosis | 1 | 2016 | 11 | 0.510 |
Why?
|
| Aged, 80 and over | 17 | 2020 | 4509 | 0.510 |
Why?
|
| Medical Errors | 2 | 2013 | 25 | 0.500 |
Why?
|
| Job Application | 1 | 2016 | 5 | 0.500 |
Why?
|
| Uterine Artery Embolization | 1 | 2016 | 2 | 0.500 |
Why?
|
| Leiomyoma | 1 | 2016 | 5 | 0.500 |
Why?
|
| Marfan Syndrome | 1 | 2015 | 3 | 0.490 |
Why?
|
| Registries | 2 | 2022 | 176 | 0.490 |
Why?
|
| Osteotomy | 8 | 2020 | 172 | 0.490 |
Why?
|
| Parturition | 1 | 2015 | 2 | 0.480 |
Why?
|
| Neostigmine | 1 | 2015 | 4 | 0.480 |
Why?
|
| Consciousness Monitors | 1 | 2015 | 1 | 0.480 |
Why?
|
| Midazolam | 2 | 2014 | 2 | 0.480 |
Why?
|
| Drug Substitution | 1 | 2015 | 4 | 0.480 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2015 | 14 | 0.480 |
Why?
|
| Logistic Models | 10 | 2015 | 365 | 0.480 |
Why?
|
| Patient Admission | 1 | 2015 | 21 | 0.480 |
Why?
|
| Magnets | 1 | 2015 | 3 | 0.470 |
Why?
|
| Esophageal Perforation | 1 | 2015 | 8 | 0.470 |
Why?
|
| Patient Preference | 1 | 2015 | 32 | 0.470 |
Why?
|
| Data Interpretation, Statistical | 5 | 2013 | 75 | 0.460 |
Why?
|
| Mastectomy | 4 | 2017 | 34 | 0.460 |
Why?
|
| Perception | 1 | 2015 | 73 | 0.460 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 33 | 0.460 |
Why?
|
| Physicians | 2 | 2013 | 103 | 0.460 |
Why?
|
| Tibia | 5 | 2018 | 244 | 0.460 |
Why?
|
| Foreign Bodies | 1 | 2015 | 22 | 0.450 |
Why?
|
| Obesity, Morbid | 2 | 2014 | 92 | 0.450 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 102 | 0.450 |
Why?
|
| Anterior Cruciate Ligament | 3 | 2016 | 182 | 0.450 |
Why?
|
| Cohort Studies | 10 | 2020 | 1748 | 0.440 |
Why?
|
| Punctures | 1 | 2014 | 7 | 0.430 |
Why?
|
| Students, Medical | 2 | 2013 | 51 | 0.430 |
Why?
|
| Radial Artery | 1 | 2014 | 5 | 0.430 |
Why?
|
| Obstetrics | 2 | 2010 | 8 | 0.430 |
Why?
|
| Ankle | 3 | 2011 | 23 | 0.430 |
Why?
|
| Risk Factors | 16 | 2018 | 2099 | 0.430 |
Why?
|
| Catheterization, Peripheral | 1 | 2014 | 15 | 0.420 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 6 | 0.420 |
Why?
|
| Respiration Disorders | 1 | 2013 | 4 | 0.420 |
Why?
|
| Magnesium Compounds | 1 | 2013 | 1 | 0.420 |
Why?
|
| User-Computer Interface | 1 | 2013 | 19 | 0.420 |
Why?
|
| Sensitivity and Specificity | 10 | 2020 | 437 | 0.410 |
Why?
|
| Chicago | 6 | 2016 | 858 | 0.410 |
Why?
|
| Pyrazoles | 1 | 2013 | 30 | 0.410 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2017 | 75 | 0.410 |
Why?
|
| Outpatients | 1 | 2013 | 51 | 0.410 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 32 | 0.410 |
Why?
|
| Analgesia | 2 | 2012 | 36 | 0.400 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 101 | 0.400 |
Why?
|
| Metoclopramide | 1 | 2012 | 4 | 0.400 |
Why?
|
| School Admission Criteria | 1 | 2012 | 9 | 0.390 |
Why?
|
| Bone Plates | 5 | 2018 | 41 | 0.390 |
Why?
|
| Biomedical Research | 1 | 2012 | 52 | 0.380 |
Why?
|
| Personnel Selection | 1 | 2012 | 20 | 0.380 |
Why?
|
| Severity of Illness Index | 7 | 2015 | 814 | 0.380 |
Why?
|
| Needles | 4 | 2009 | 17 | 0.380 |
Why?
|
| Endarterectomy, Carotid | 2 | 2002 | 3 | 0.380 |
Why?
|
| Publication Bias | 1 | 2012 | 4 | 0.380 |
Why?
|
| Stifle | 4 | 2020 | 10 | 0.380 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2012 | 56 | 0.370 |
Why?
|
| Ovariectomy | 1 | 2011 | 26 | 0.370 |
Why?
|
| Patellar Dislocation | 2 | 2016 | 23 | 0.370 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 18 | 0.370 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2014 | 138 | 0.370 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2012 | 85 | 0.360 |
Why?
|
| Evoked Potentials, Motor | 2 | 2009 | 10 | 0.360 |
Why?
|
| Medication Errors | 1 | 2011 | 11 | 0.360 |
Why?
|
| Motor Activity | 2 | 2013 | 308 | 0.360 |
Why?
|
| Laryngoscopy | 2 | 2011 | 18 | 0.360 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 560 | 0.350 |
Why?
|
| Optical Devices | 1 | 2011 | 1 | 0.350 |
Why?
|
| Laryngoscopes | 1 | 2011 | 5 | 0.350 |
Why?
|
| Academic Medical Centers | 2 | 2014 | 117 | 0.350 |
Why?
|
| Administrative Personnel | 1 | 2011 | 8 | 0.350 |
Why?
|
| Osteoarthritis | 2 | 2013 | 328 | 0.350 |
Why?
|
| Postoperative Care | 2 | 2011 | 131 | 0.350 |
Why?
|
| Knee Joint | 1 | 2016 | 744 | 0.350 |
Why?
|
| Arthralgia | 1 | 2012 | 132 | 0.340 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2022 | 5 | 0.340 |
Why?
|
| Tendons | 2 | 2011 | 220 | 0.340 |
Why?
|
| Spine | 2 | 2021 | 100 | 0.340 |
Why?
|
| Deep Sedation | 1 | 2010 | 1 | 0.340 |
Why?
|
| Pregnancy Complications | 4 | 2014 | 43 | 0.330 |
Why?
|
| Headache | 2 | 2013 | 33 | 0.330 |
Why?
|
| Follow-Up Studies | 7 | 2020 | 1671 | 0.320 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 113 | 0.320 |
Why?
|
| Sensory Thresholds | 1 | 2009 | 23 | 0.320 |
Why?
|
| International Normalized Ratio | 2 | 2021 | 18 | 0.320 |
Why?
|
| Depression | 1 | 2013 | 390 | 0.320 |
Why?
|
| Pancreatic Neoplasms | 3 | 2020 | 86 | 0.320 |
Why?
|
| Rats | 10 | 2022 | 609 | 0.320 |
Why?
|
| Predictive Value of Tests | 9 | 2019 | 412 | 0.320 |
Why?
|
| Breast Neoplasms | 5 | 2017 | 374 | 0.310 |
Why?
|
| Rest | 3 | 2015 | 30 | 0.310 |
Why?
|
| Myocardial Ischemia | 2 | 1999 | 29 | 0.310 |
Why?
|
| Electrodes | 1 | 2009 | 12 | 0.310 |
Why?
|
| Hemodynamics | 13 | 2013 | 56 | 0.310 |
Why?
|
| Diagnosis, Differential | 8 | 2020 | 315 | 0.300 |
Why?
|
| Age Distribution | 3 | 2015 | 81 | 0.300 |
Why?
|
| Internet | 3 | 2015 | 80 | 0.300 |
Why?
|
| Body Weight | 7 | 2017 | 128 | 0.300 |
Why?
|
| Radiography | 8 | 2016 | 611 | 0.300 |
Why?
|
| Infant, Newborn | 7 | 2018 | 536 | 0.300 |
Why?
|
| Catheters | 2 | 2021 | 15 | 0.300 |
Why?
|
| Suture Techniques | 2 | 2009 | 156 | 0.300 |
Why?
|
| Movement | 3 | 2015 | 110 | 0.290 |
Why?
|
| Injections | 4 | 2014 | 42 | 0.290 |
Why?
|
| Single-Blind Method | 5 | 2017 | 99 | 0.280 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2022 | 35 | 0.280 |
Why?
|
| Nitrous Oxide | 2 | 2006 | 2 | 0.270 |
Why?
|
| Sample Size | 5 | 2015 | 17 | 0.270 |
Why?
|
| Lameness, Animal | 4 | 2014 | 5 | 0.260 |
Why?
|
| Radiculopathy | 2 | 2017 | 41 | 0.260 |
Why?
|
| China | 2 | 2018 | 47 | 0.260 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2009 | 195 | 0.260 |
Why?
|
| Length of Stay | 4 | 2020 | 294 | 0.250 |
Why?
|
| Blood Pressure | 17 | 2003 | 173 | 0.250 |
Why?
|
| Placebos | 3 | 2017 | 60 | 0.250 |
Why?
|
| Catheters, Indwelling | 2 | 2017 | 21 | 0.250 |
Why?
|
| Patient Discharge | 3 | 2012 | 143 | 0.250 |
Why?
|
| Pharyngitis | 3 | 2017 | 7 | 0.250 |
Why?
|
| Spinal Puncture | 3 | 2022 | 23 | 0.250 |
Why?
|
| Administration, Oral | 3 | 2017 | 97 | 0.250 |
Why?
|
| Pregnancy Outcome | 4 | 2015 | 19 | 0.240 |
Why?
|
| ROC Curve | 6 | 2019 | 131 | 0.240 |
Why?
|
| Intestinal Volvulus | 1 | 2005 | 1 | 0.240 |
Why?
|
| Colonic Diseases | 1 | 2005 | 6 | 0.240 |
Why?
|
| Adolescent | 9 | 2015 | 1992 | 0.240 |
Why?
|
| Leadership | 2 | 2019 | 89 | 0.240 |
Why?
|
| Heart Rate | 10 | 2003 | 94 | 0.240 |
Why?
|
| Thoracic Vertebrae | 2 | 2017 | 88 | 0.230 |
Why?
|
| Breast Feeding | 2 | 2017 | 139 | 0.230 |
Why?
|
| Reference Standards | 2 | 2021 | 18 | 0.230 |
Why?
|
| Unconsciousness | 1 | 2005 | 7 | 0.230 |
Why?
|
| Ultrasonography | 7 | 2020 | 202 | 0.230 |
Why?
|
| Benzocaine | 2 | 2002 | 4 | 0.230 |
Why?
|
| Blood Coagulation | 5 | 2019 | 20 | 0.230 |
Why?
|
| Infusion Pumps, Implantable | 2 | 2019 | 5 | 0.230 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 332 | 0.230 |
Why?
|
| Pain Threshold | 3 | 2014 | 25 | 0.230 |
Why?
|
| Anxiety | 2 | 2014 | 135 | 0.220 |
Why?
|
| Colon | 1 | 2005 | 108 | 0.220 |
Why?
|
| Anticoagulants | 3 | 2022 | 78 | 0.220 |
Why?
|
| Infusions, Intravenous | 6 | 2018 | 51 | 0.220 |
Why?
|
| Breech Presentation | 2 | 2017 | 3 | 0.220 |
Why?
|
| Version, Fetal | 2 | 2017 | 3 | 0.220 |
Why?
|
| Injections, Intravenous | 6 | 2015 | 23 | 0.220 |
Why?
|
| Career Choice | 2 | 2016 | 24 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 398 | 0.210 |
Why?
|
| Cough | 2 | 2013 | 9 | 0.210 |
Why?
|
| Odds Ratio | 3 | 2015 | 251 | 0.210 |
Why?
|
| Breakthrough Pain | 1 | 2023 | 3 | 0.210 |
Why?
|
| Mice | 3 | 2022 | 1296 | 0.210 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2015 | 8 | 0.210 |
Why?
|
| Analgesia, Patient-Controlled | 4 | 2012 | 22 | 0.210 |
Why?
|
| Posture | 1 | 2003 | 59 | 0.210 |
Why?
|
| Anesthesiologists | 2 | 2023 | 6 | 0.210 |
Why?
|
| Hypotension | 6 | 2012 | 21 | 0.200 |
Why?
|
| Obstetric Labor Complications | 1 | 2003 | 1 | 0.200 |
Why?
|
| Lumbosacral Plexus | 1 | 2003 | 4 | 0.200 |
Why?
|
| Acute Pain | 1 | 2023 | 23 | 0.200 |
Why?
|
| Liver Cirrhosis | 2 | 2015 | 41 | 0.200 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2003 | 26 | 0.200 |
Why?
|
| Machine Learning | 2 | 2020 | 77 | 0.200 |
Why?
|
| Tendon Injuries | 1 | 2005 | 203 | 0.200 |
Why?
|
| Labor, Induced | 2 | 2015 | 3 | 0.200 |
Why?
|
| Adenosine Monophosphate | 1 | 2022 | 5 | 0.200 |
Why?
|
| Mammals | 1 | 2022 | 17 | 0.200 |
Why?
|
| Anesthetics, General | 1 | 2002 | 1 | 0.200 |
Why?
|
| Survival Rate | 5 | 2011 | 285 | 0.200 |
Why?
|
| Faculty | 2 | 2013 | 24 | 0.200 |
Why?
|
| Carotid Artery Diseases | 1 | 2002 | 12 | 0.200 |
Why?
|
| Illinois | 2 | 2015 | 221 | 0.190 |
Why?
|
| Cerebrovascular Circulation | 1 | 2002 | 28 | 0.190 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 1999 | 24 | 0.190 |
Why?
|
| Peer Review, Research | 2 | 2012 | 5 | 0.190 |
Why?
|
| Trauma Centers | 1 | 2022 | 9 | 0.190 |
Why?
|
| Triage | 1 | 2022 | 18 | 0.190 |
Why?
|
| Upper Extremity | 1 | 2022 | 61 | 0.190 |
Why?
|
| Hyperalgesia | 1 | 2022 | 46 | 0.190 |
Why?
|
| Bone Neoplasms | 2 | 2018 | 122 | 0.190 |
Why?
|
| Turtles | 1 | 2021 | 1 | 0.190 |
Why?
|
| Partial Thromboplastin Time | 2 | 2019 | 6 | 0.190 |
Why?
|
| Magnesium Sulfate | 2 | 2000 | 6 | 0.190 |
Why?
|
| Education, Medical, Graduate | 2 | 2012 | 72 | 0.180 |
Why?
|
| Osteomyelitis | 1 | 2021 | 18 | 0.180 |
Why?
|
| Sex Distribution | 2 | 2012 | 72 | 0.180 |
Why?
|
| Analysis of Variance | 5 | 2013 | 243 | 0.180 |
Why?
|
| Abdomen | 2 | 2011 | 7 | 0.180 |
Why?
|
| Propensity Score | 2 | 2018 | 31 | 0.180 |
Why?
|
| Blood Coagulation Disorders | 4 | 2019 | 12 | 0.180 |
Why?
|
| Phenylephrine | 2 | 2018 | 4 | 0.180 |
Why?
|
| Probability | 2 | 2016 | 83 | 0.180 |
Why?
|
| Ontario | 1 | 2021 | 16 | 0.180 |
Why?
|
| Chronic Disease | 4 | 2011 | 384 | 0.180 |
Why?
|
| Oxytocin | 2 | 2015 | 4 | 0.170 |
Why?
|
| Ephedrine | 3 | 2018 | 5 | 0.170 |
Why?
|
| Catastrophization | 1 | 2021 | 23 | 0.170 |
Why?
|
| Blood Coagulation Tests | 4 | 2019 | 12 | 0.170 |
Why?
|
| Omentum | 1 | 2020 | 6 | 0.170 |
Why?
|
| Progesterone | 1 | 2020 | 19 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 63 | 0.170 |
Why?
|
| Case-Control Studies | 3 | 2018 | 555 | 0.170 |
Why?
|
| Injections, Epidural | 7 | 2017 | 15 | 0.170 |
Why?
|
| Ovary | 1 | 2020 | 21 | 0.170 |
Why?
|
| Appendix | 1 | 2020 | 2 | 0.170 |
Why?
|
| Pre-Eclampsia | 2 | 2018 | 6 | 0.170 |
Why?
|
| Blood Gas Analysis | 2 | 2018 | 5 | 0.170 |
Why?
|
| Cyclodextrins | 1 | 2020 | 7 | 0.170 |
Why?
|
| Obesity | 2 | 2017 | 280 | 0.170 |
Why?
|
| Appendicitis | 1 | 2020 | 14 | 0.170 |
Why?
|
| Task Performance and Analysis | 2 | 2010 | 46 | 0.170 |
Why?
|
| Clonidine | 3 | 2003 | 17 | 0.160 |
Why?
|
| Neck Pain | 2 | 2017 | 26 | 0.160 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2020 | 21 | 0.160 |
Why?
|
| Myocardial Contraction | 2 | 1999 | 38 | 0.160 |
Why?
|
| Fellowships and Scholarships | 2 | 2023 | 33 | 0.160 |
Why?
|
| Foot | 2 | 2011 | 42 | 0.160 |
Why?
|
| Educational Measurement | 2 | 2010 | 54 | 0.160 |
Why?
|
| Aprotinin | 1 | 1999 | 1 | 0.160 |
Why?
|
| Edema | 1 | 2020 | 25 | 0.160 |
Why?
|
| Metformin | 1 | 2020 | 16 | 0.160 |
Why?
|
| Hemostatics | 1 | 1999 | 11 | 0.160 |
Why?
|
| Program Evaluation | 1 | 2020 | 112 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 31 | 0.160 |
Why?
|
| Monitoring, Physiologic | 5 | 2006 | 64 | 0.160 |
Why?
|
| Prothrombin Time | 1 | 2019 | 1 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 5 | 2003 | 24 | 0.160 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 134 | 0.160 |
Why?
|
| Endosonography | 1 | 2019 | 7 | 0.160 |
Why?
|
| Prognosis | 9 | 2018 | 674 | 0.160 |
Why?
|
| Prostate-Specific Antigen | 1 | 2019 | 14 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 183 | 0.160 |
Why?
|
| Administration, Intravenous | 2 | 2017 | 20 | 0.150 |
Why?
|
| Hypoxia | 2 | 2010 | 27 | 0.150 |
Why?
|
| Image-Guided Biopsy | 1 | 2019 | 28 | 0.150 |
Why?
|
| Sexism | 1 | 2019 | 6 | 0.150 |
Why?
|
| Prostate | 1 | 2019 | 29 | 0.150 |
Why?
|
| Women, Working | 1 | 2019 | 9 | 0.150 |
Why?
|
| Physicians, Women | 1 | 2019 | 14 | 0.150 |
Why?
|
| Pain Perception | 1 | 2018 | 5 | 0.150 |
Why?
|
| Umbilical Arteries | 1 | 2018 | 4 | 0.150 |
Why?
|
| Osteosarcoma | 1 | 2018 | 34 | 0.150 |
Why?
|
| Patient Simulation | 2 | 2010 | 11 | 0.150 |
Why?
|
| Data Collection | 2 | 2012 | 86 | 0.150 |
Why?
|
| Intraoperative Period | 2 | 2010 | 22 | 0.150 |
Why?
|
| Warfarin | 1 | 2018 | 24 | 0.150 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1998 | 14 | 0.140 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 85 | 0.140 |
Why?
|
| Pilot Projects | 2 | 2020 | 370 | 0.140 |
Why?
|
| Area Under Curve | 3 | 2016 | 60 | 0.140 |
Why?
|
| Pruritus | 5 | 2010 | 10 | 0.140 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 279 | 0.140 |
Why?
|
| Muscle Weakness | 1 | 2017 | 32 | 0.140 |
Why?
|
| Steroids | 2 | 2017 | 22 | 0.140 |
Why?
|
| Motor Neurons | 3 | 2009 | 15 | 0.140 |
Why?
|
| Hoarseness | 1 | 2017 | 1 | 0.140 |
Why?
|
| Denervation | 1 | 2017 | 20 | 0.140 |
Why?
|
| Deglutition Disorders | 1 | 2017 | 30 | 0.140 |
Why?
|
| Bone Screws | 3 | 2015 | 141 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2016 | 6 | 0.130 |
Why?
|
| Lung Diseases | 1 | 2017 | 42 | 0.130 |
Why?
|
| Intracranial Aneurysm | 1 | 2016 | 36 | 0.130 |
Why?
|
| Conscious Sedation | 1 | 2016 | 4 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2016 | 37 | 0.130 |
Why?
|
| Young Adult | 4 | 2015 | 1847 | 0.130 |
Why?
|
| Preoperative Care | 3 | 2014 | 118 | 0.130 |
Why?
|
| Range of Motion, Articular | 2 | 2012 | 708 | 0.130 |
Why?
|
| Academies and Institutes | 1 | 2016 | 11 | 0.120 |
Why?
|
| Orthopedic Procedures | 2 | 2011 | 310 | 0.120 |
Why?
|
| Sacroiliac Joint | 1 | 2015 | 9 | 0.120 |
Why?
|
| Placenta Diseases | 1 | 2015 | 1 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 278 | 0.120 |
Why?
|
| Protective Factors | 1 | 2015 | 20 | 0.120 |
Why?
|
| Labor Stage, Third | 1 | 2015 | 1 | 0.120 |
Why?
|
| Oxytocics | 1 | 2015 | 1 | 0.120 |
Why?
|
| Uterine Inertia | 1 | 2015 | 1 | 0.120 |
Why?
|
| Placenta | 1 | 2015 | 7 | 0.120 |
Why?
|
| Health Surveys | 1 | 2015 | 84 | 0.120 |
Why?
|
| Breast | 1 | 2015 | 20 | 0.120 |
Why?
|
| Carbon Dioxide | 3 | 2016 | 13 | 0.120 |
Why?
|
| Myocardial Infarction | 3 | 2012 | 102 | 0.120 |
Why?
|
| Informed Consent | 1 | 2015 | 22 | 0.120 |
Why?
|
| Spinal Cord | 4 | 2006 | 75 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2002 | 312 | 0.120 |
Why?
|
| Necrosis | 1 | 2015 | 23 | 0.120 |
Why?
|
| Scoliosis | 1 | 2015 | 34 | 0.120 |
Why?
|
| Physical Examination | 1 | 2015 | 114 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2015 | 51 | 0.120 |
Why?
|
| Databases, Bibliographic | 1 | 2015 | 7 | 0.120 |
Why?
|
| Mucous Membrane | 1 | 2015 | 24 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2015 | 315 | 0.120 |
Why?
|
| Joint Dislocations | 1 | 2015 | 55 | 0.120 |
Why?
|
| High-Energy Shock Waves | 1 | 2014 | 1 | 0.120 |
Why?
|
| Cold Temperature | 2 | 2014 | 23 | 0.120 |
Why?
|
| Forelimb | 1 | 2014 | 5 | 0.120 |
Why?
|
| Wound Healing | 2 | 2013 | 151 | 0.110 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2014 | 4 | 0.110 |
Why?
|
| Biopsy | 1 | 2015 | 184 | 0.110 |
Why?
|
| Postoperative Period | 3 | 2015 | 322 | 0.110 |
Why?
|
| Hospitals, Urban | 1 | 2014 | 34 | 0.110 |
Why?
|
| Research | 1 | 2014 | 36 | 0.110 |
Why?
|
| Preanesthetic Medication | 3 | 2011 | 3 | 0.110 |
Why?
|
| Calcinosis | 1 | 2014 | 37 | 0.110 |
Why?
|
| Operative Time | 1 | 2015 | 77 | 0.110 |
Why?
|
| Laryngitis | 1 | 1994 | 2 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 613 | 0.110 |
Why?
|
| Granuloma | 1 | 1994 | 12 | 0.110 |
Why?
|
| Venous Thromboembolism | 1 | 2015 | 35 | 0.110 |
Why?
|
| Sex Factors | 2 | 2015 | 443 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 116 | 0.110 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 51 | 0.110 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 44 | 0.110 |
Why?
|
| Patient Compliance | 1 | 2015 | 144 | 0.110 |
Why?
|
| Blood Loss, Surgical | 3 | 2016 | 53 | 0.110 |
Why?
|
| Hot Temperature | 1 | 2014 | 21 | 0.110 |
Why?
|
| Regression Analysis | 2 | 2014 | 240 | 0.110 |
Why?
|
| Observer Variation | 3 | 2010 | 95 | 0.110 |
Why?
|
| Exercise Test | 2 | 2012 | 57 | 0.110 |
Why?
|
| Mammaplasty | 1 | 2014 | 6 | 0.110 |
Why?
|
| Liver | 1 | 2015 | 142 | 0.110 |
Why?
|
| Psychomotor Performance | 2 | 2013 | 178 | 0.110 |
Why?
|
| Anesthetics, Combined | 1 | 2013 | 1 | 0.110 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2013 | 15 | 0.110 |
Why?
|
| Laryngismus | 1 | 2013 | 1 | 0.110 |
Why?
|
| Euthanasia, Animal | 1 | 2013 | 1 | 0.110 |
Why?
|
| Animals, Wild | 1 | 2013 | 2 | 0.110 |
Why?
|
| Population Density | 1 | 2013 | 3 | 0.110 |
Why?
|
| Shivering | 1 | 2013 | 2 | 0.100 |
Why?
|
| Vasectomy | 1 | 2013 | 5 | 0.100 |
Why?
|
| Age Factors | 4 | 2016 | 728 | 0.100 |
Why?
|
| Endpoint Determination | 1 | 2013 | 20 | 0.100 |
Why?
|
| Neurons, Afferent | 2 | 2003 | 6 | 0.100 |
Why?
|
| Dizziness | 1 | 2013 | 16 | 0.100 |
Why?
|
| Software | 1 | 2013 | 55 | 0.100 |
Why?
|
| Airway Management | 1 | 2013 | 15 | 0.100 |
Why?
|
| Bradycardia | 2 | 2012 | 21 | 0.100 |
Why?
|
| Cervical Vertebrae | 1 | 2017 | 274 | 0.100 |
Why?
|
| Joint Diseases | 2 | 2005 | 115 | 0.100 |
Why?
|
| Risk Assessment | 4 | 2017 | 532 | 0.100 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1993 | 4 | 0.100 |
Why?
|
| Brachial Plexus | 1 | 1993 | 5 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 4 | 0.100 |
Why?
|
| Inflammation | 1 | 2014 | 258 | 0.100 |
Why?
|
| Efficiency | 1 | 2012 | 21 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2013 | 62 | 0.100 |
Why?
|
| Work Schedule Tolerance | 1 | 2013 | 24 | 0.100 |
Why?
|
| Ischemia | 2 | 2003 | 21 | 0.100 |
Why?
|
| Glucocorticoids | 2 | 2017 | 59 | 0.100 |
Why?
|
| Foreign Medical Graduates | 1 | 2012 | 2 | 0.100 |
Why?
|
| Licensure, Medical | 1 | 2012 | 2 | 0.100 |
Why?
|
| Specialty Boards | 1 | 2012 | 4 | 0.100 |
Why?
|
| Cross-Over Studies | 2 | 2010 | 61 | 0.100 |
Why?
|
| Authorship | 1 | 2012 | 13 | 0.100 |
Why?
|
| Endovascular Procedures | 1 | 2012 | 28 | 0.100 |
Why?
|
| Equipment Design | 2 | 2011 | 122 | 0.100 |
Why?
|
| Stomach Neoplasms | 1 | 2012 | 29 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2012 | 69 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2012 | 24 | 0.090 |
Why?
|
| Research Support as Topic | 1 | 2012 | 12 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2012 | 38 | 0.090 |
Why?
|
| Sterilization, Reproductive | 1 | 2011 | 1 | 0.090 |
Why?
|
| Endoscopy | 1 | 2013 | 168 | 0.090 |
Why?
|
| Oxygen | 5 | 2016 | 59 | 0.090 |
Why?
|
| Stress, Psychological | 2 | 2011 | 217 | 0.090 |
Why?
|
| Prevalence | 1 | 2013 | 411 | 0.090 |
Why?
|
| Urinary Incontinence | 1 | 2011 | 18 | 0.090 |
Why?
|
| Ticlopidine | 1 | 2011 | 5 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2012 | 52 | 0.090 |
Why?
|
| Job Satisfaction | 2 | 2011 | 13 | 0.090 |
Why?
|
| Piperidines | 1 | 2011 | 12 | 0.090 |
Why?
|
| Intracranial Pressure | 2 | 2002 | 12 | 0.090 |
Why?
|
| Bibliometrics | 1 | 2012 | 26 | 0.090 |
Why?
|
| Statistics, Nonparametric | 3 | 2011 | 115 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 93 | 0.090 |
Why?
|
| Palliative Care | 1 | 2012 | 104 | 0.090 |
Why?
|
| Yohimbine | 2 | 1996 | 6 | 0.090 |
Why?
|
| Embolism, Air | 6 | 1988 | 9 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 145 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2012 | 123 | 0.090 |
Why?
|
| Drug Recalls | 1 | 2011 | 1 | 0.090 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2011 | 36 | 0.090 |
Why?
|
| Equipment Failure Analysis | 1 | 2011 | 96 | 0.090 |
Why?
|
| Hepatitis, Chronic | 1 | 2011 | 1 | 0.090 |
Why?
|
| Sensation | 2 | 2009 | 12 | 0.090 |
Why?
|
| Intervertebral Disc | 1 | 2012 | 117 | 0.090 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 2 | 2010 | 3 | 0.090 |
Why?
|
| Manikins | 1 | 2011 | 3 | 0.090 |
Why?
|
| Anesthetics, Dissociative | 1 | 2011 | 2 | 0.090 |
Why?
|
| Secondary Prevention | 1 | 2011 | 49 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2011 | 11 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 193 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2011 | 145 | 0.090 |
Why?
|
| Thrombelastography | 4 | 1994 | 5 | 0.090 |
Why?
|
| Video Recording | 1 | 2010 | 31 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 91 | 0.090 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 25 | 0.090 |
Why?
|
| Atrial Fibrillation | 1 | 2012 | 79 | 0.090 |
Why?
|
| Image Enhancement | 1 | 2011 | 44 | 0.090 |
Why?
|
| Rh Isoimmunization | 1 | 2010 | 1 | 0.090 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2010 | 1 | 0.090 |
Why?
|
| Carcinoma | 1 | 2011 | 65 | 0.090 |
Why?
|
| Research Design | 1 | 2012 | 172 | 0.090 |
Why?
|
| Educational Status | 2 | 2010 | 278 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2010 | 32 | 0.080 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 50 | 0.080 |
Why?
|
| Partial Pressure | 1 | 2010 | 1 | 0.080 |
Why?
|
| Capnography | 1 | 2010 | 8 | 0.080 |
Why?
|
| Cervix Uteri | 1 | 2010 | 12 | 0.080 |
Why?
|
| Cardiac Output | 6 | 2002 | 12 | 0.080 |
Why?
|
| Receptors, Opioid, mu | 1 | 2010 | 2 | 0.080 |
Why?
|
| Lipoma | 1 | 2010 | 4 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2011 | 156 | 0.080 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2010 | 10 | 0.080 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2003 | 12 | 0.080 |
Why?
|
| Tibial Nerve | 1 | 2009 | 4 | 0.080 |
Why?
|
| Sural Nerve | 1 | 2009 | 3 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2011 | 286 | 0.080 |
Why?
|
| Safety | 1 | 2010 | 35 | 0.080 |
Why?
|
| Inservice Training | 1 | 2009 | 25 | 0.080 |
Why?
|
| Diskectomy | 1 | 2012 | 167 | 0.080 |
Why?
|
| Nociceptors | 1 | 1990 | 20 | 0.080 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2011 | 153 | 0.080 |
Why?
|
| Computer-Assisted Instruction | 1 | 2009 | 20 | 0.080 |
Why?
|
| Neurologic Examination | 1 | 2009 | 97 | 0.080 |
Why?
|
| Procaine | 1 | 2009 | 2 | 0.080 |
Why?
|
| Liver Transplantation | 4 | 1993 | 85 | 0.080 |
Why?
|
| Social Support | 1 | 2011 | 183 | 0.080 |
Why?
|
| Hoof and Claw | 1 | 2009 | 1 | 0.080 |
Why?
|
| Papillomaviridae | 1 | 2009 | 17 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2009 | 19 | 0.080 |
Why?
|
| Biocompatible Materials | 2 | 2007 | 88 | 0.080 |
Why?
|
| Monoamine Oxidase Inhibitors | 2 | 1987 | 16 | 0.080 |
Why?
|
| Mass Screening | 1 | 2010 | 165 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2009 | 62 | 0.070 |
Why?
|
| Labor Stage, Second | 1 | 2008 | 1 | 0.070 |
Why?
|
| Obstetrical Forceps | 1 | 2008 | 1 | 0.070 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2008 | 1 | 0.070 |
Why?
|
| Anesthesia, Intravenous | 4 | 2014 | 5 | 0.070 |
Why?
|
| Child | 3 | 2022 | 1131 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1293 | 0.070 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2009 | 86 | 0.070 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2008 | 50 | 0.070 |
Why?
|
| Gastric Emptying | 1 | 2007 | 12 | 0.070 |
Why?
|
| Stomach | 1 | 2007 | 13 | 0.070 |
Why?
|
| Water | 1 | 2007 | 22 | 0.070 |
Why?
|
| Aging | 2 | 2013 | 1460 | 0.070 |
Why?
|
| Fluorocarbons | 4 | 1988 | 11 | 0.070 |
Why?
|
| Internal Fixators | 1 | 2007 | 37 | 0.070 |
Why?
|
| Lumbar Vertebrae | 1 | 2012 | 356 | 0.070 |
Why?
|
| Shock, Septic | 2 | 1998 | 59 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2016 | 27 | 0.070 |
Why?
|
| Quality of Life | 2 | 2023 | 541 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 2 | 1995 | 27 | 0.070 |
Why?
|
| Heart Rate, Fetal | 2 | 2004 | 5 | 0.070 |
Why?
|
| Nausea | 3 | 1998 | 23 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 221 | 0.070 |
Why?
|
| Vomiting | 3 | 1998 | 18 | 0.070 |
Why?
|
| Ferrets | 1 | 2006 | 4 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2007 | 52 | 0.070 |
Why?
|
| Heart Block | 1 | 2006 | 5 | 0.070 |
Why?
|
| Pacemaker, Artificial | 1 | 2006 | 11 | 0.060 |
Why?
|
| Soft Tissue Injuries | 1 | 2006 | 19 | 0.060 |
Why?
|
| Limb Salvage | 2 | 2003 | 11 | 0.060 |
Why?
|
| Reoperation | 2 | 2009 | 879 | 0.060 |
Why?
|
| Attitude | 2 | 1996 | 32 | 0.060 |
Why?
|
| Sterilization, Tubal | 1 | 2005 | 1 | 0.060 |
Why?
|
| Cadaver | 2 | 2004 | 372 | 0.060 |
Why?
|
| Gastric Dilatation | 1 | 2005 | 1 | 0.060 |
Why?
|
| Drug Interactions | 3 | 2009 | 34 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 369 | 0.060 |
Why?
|
| Anastomosis, Surgical | 1 | 2005 | 23 | 0.060 |
Why?
|
| Electroconvulsive Therapy | 1 | 1985 | 13 | 0.060 |
Why?
|
| Drug Synergism | 3 | 2002 | 36 | 0.060 |
Why?
|
| Coronary Disease | 4 | 1992 | 49 | 0.060 |
Why?
|
| Spinal Nerves | 2 | 2003 | 3 | 0.060 |
Why?
|
| Spinal Diseases | 1 | 2006 | 109 | 0.060 |
Why?
|
| Rupture | 1 | 2005 | 109 | 0.060 |
Why?
|
| Comprehension | 2 | 2015 | 29 | 0.060 |
Why?
|
| Hip Dysplasia, Canine | 1 | 2004 | 1 | 0.060 |
Why?
|
| Suspensions | 2 | 2002 | 3 | 0.060 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2004 | 9 | 0.060 |
Why?
|
| Pelvis | 1 | 2004 | 24 | 0.060 |
Why?
|
| Sarcoma | 1 | 2005 | 71 | 0.060 |
Why?
|
| Humeral Fractures | 1 | 2004 | 21 | 0.060 |
Why?
|
| Shoulder | 1 | 2006 | 187 | 0.060 |
Why?
|
| Kidney | 1 | 2005 | 139 | 0.060 |
Why?
|
| Pericardial Effusion | 1 | 2004 | 5 | 0.060 |
Why?
|
| Critical Care | 2 | 2022 | 112 | 0.050 |
Why?
|
| Algorithms | 2 | 2005 | 330 | 0.050 |
Why?
|
| Plasma | 2 | 2021 | 15 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2004 | 17 | 0.050 |
Why?
|
| Pulmonary Artery | 4 | 1993 | 29 | 0.050 |
Why?
|
| Emulsions | 2 | 2002 | 2 | 0.050 |
Why?
|
| Cholesterol | 1 | 2004 | 58 | 0.050 |
Why?
|
| Random Allocation | 3 | 2020 | 121 | 0.050 |
Why?
|
| Atmosphere | 1 | 2003 | 1 | 0.050 |
Why?
|
| Body Height | 1 | 2003 | 35 | 0.050 |
Why?
|
| Arthroscopy | 2 | 2011 | 1095 | 0.050 |
Why?
|
| Risk | 2 | 2019 | 199 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2003 | 14 | 0.050 |
Why?
|
| Peroneal Neuropathies | 1 | 2003 | 1 | 0.050 |
Why?
|
| Tibial Neuropathy | 1 | 2003 | 1 | 0.050 |
Why?
|
| Hypothyroidism | 1 | 2004 | 69 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2003 | 17 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2003 | 36 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2003 | 87 | 0.050 |
Why?
|
| Phospholipids | 1 | 2002 | 9 | 0.050 |
Why?
|
| Respiratory System | 1 | 2002 | 7 | 0.050 |
Why?
|
| Middle Cerebral Artery | 1 | 2002 | 6 | 0.050 |
Why?
|
| Indans | 1 | 2002 | 5 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2002 | 17 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 24 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 84 | 0.050 |
Why?
|
| Tarsal Joints | 1 | 2002 | 1 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 26 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 48 | 0.050 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 9 | 0.050 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 149 | 0.050 |
Why?
|
| Hip | 1 | 2003 | 66 | 0.050 |
Why?
|
| Intermittent Claudication | 1 | 2002 | 3 | 0.050 |
Why?
|
| Decompression | 1 | 2022 | 21 | 0.050 |
Why?
|
| Arthrodesis | 1 | 2002 | 34 | 0.050 |
Why?
|
| Thoracotomy | 3 | 2004 | 26 | 0.050 |
Why?
|
| Leg | 1 | 2002 | 46 | 0.050 |
Why?
|
| Peripheral Nerves | 1 | 2022 | 16 | 0.050 |
Why?
|
| Drug Combinations | 3 | 1998 | 31 | 0.050 |
Why?
|
| Depression, Chemical | 2 | 1999 | 5 | 0.050 |
Why?
|
| Infant | 1 | 2023 | 482 | 0.050 |
Why?
|
| Peritonitis | 2 | 2002 | 17 | 0.050 |
Why?
|
| Sepsis | 1 | 2002 | 110 | 0.050 |
Why?
|
| Surface Properties | 2 | 2018 | 129 | 0.040 |
Why?
|
| Hydrocephalus | 1 | 2000 | 16 | 0.040 |
Why?
|
| Pancreatic Ducts | 1 | 2020 | 1 | 0.040 |
Why?
|
| Biomarkers | 1 | 2023 | 520 | 0.040 |
Why?
|
| Radiologists | 1 | 2020 | 7 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 32 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2000 | 23 | 0.040 |
Why?
|
| Droperidol | 2 | 1998 | 7 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2020 | 13 | 0.040 |
Why?
|
| 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2020 | 7 | 0.040 |
Why?
|
| Colorado | 1 | 2020 | 5 | 0.040 |
Why?
|
| Contrast Media | 2 | 2011 | 56 | 0.040 |
Why?
|
| Tibial Fractures | 1 | 2020 | 7 | 0.040 |
Why?
|
| Hip Joint | 2 | 2005 | 543 | 0.040 |
Why?
|
| Myocardial Reperfusion | 1 | 1999 | 5 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 34 | 0.040 |
Why?
|
| Polysomnography | 2 | 2010 | 71 | 0.040 |
Why?
|
| Lupus Coagulation Inhibitor | 1 | 2019 | 7 | 0.040 |
Why?
|
| Hospitals | 1 | 2020 | 149 | 0.040 |
Why?
|
| Rectum | 1 | 2019 | 46 | 0.040 |
Why?
|
| Thrombosis | 1 | 2019 | 37 | 0.040 |
Why?
|
| Fluconazole | 1 | 1998 | 7 | 0.040 |
Why?
|
| Cryptococcosis | 1 | 1998 | 6 | 0.040 |
Why?
|
| Lipoproteins | 1 | 1998 | 10 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2018 | 8 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 362 | 0.040 |
Why?
|
| Stainless Steel | 1 | 2018 | 15 | 0.040 |
Why?
|
| Spinal Cord Compression | 1 | 1998 | 23 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 1998 | 38 | 0.040 |
Why?
|
| Education, Medical | 1 | 2019 | 44 | 0.040 |
Why?
|
| Heart | 1 | 1998 | 48 | 0.040 |
Why?
|
| Dizocilpine Maleate | 1 | 1998 | 2 | 0.040 |
Why?
|
| Drug Tolerance | 1 | 1998 | 6 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 1998 | 13 | 0.040 |
Why?
|
| Naloxone | 1 | 1998 | 13 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 89 | 0.040 |
Why?
|
| Corrosion | 1 | 2018 | 119 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1998 | 26 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1998 | 34 | 0.040 |
Why?
|
| Triamcinolone Acetonide | 1 | 2017 | 7 | 0.040 |
Why?
|
| Materials Testing | 1 | 2018 | 121 | 0.040 |
Why?
|
| Hand Strength | 1 | 2017 | 53 | 0.030 |
Why?
|
| Equipment Failure | 2 | 1994 | 37 | 0.030 |
Why?
|
| Swine | 4 | 2002 | 63 | 0.030 |
Why?
|
| Arm | 1 | 2017 | 83 | 0.030 |
Why?
|
| Multivariate Analysis | 4 | 2005 | 304 | 0.030 |
Why?
|
| Aneurysm, Ruptured | 1 | 2016 | 14 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2016 | 30 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 348 | 0.030 |
Why?
|
| Parasympatholytics | 1 | 1996 | 3 | 0.030 |
Why?
|
| Sympatholytics | 1 | 1996 | 7 | 0.030 |
Why?
|
| Coronary Circulation | 3 | 1996 | 24 | 0.030 |
Why?
|
| Aspirin | 1 | 1996 | 56 | 0.030 |
Why?
|
| Bacteremia | 1 | 1996 | 97 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2016 | 96 | 0.030 |
Why?
|
| Visual Analog Scale | 1 | 2016 | 82 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2015 | 9 | 0.030 |
Why?
|
| Discriminant Analysis | 2 | 2012 | 9 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 9 | 0.030 |
Why?
|
| Ambulatory Care | 2 | 1993 | 61 | 0.030 |
Why?
|
| Gestational Age | 1 | 2015 | 73 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 1995 | 2 | 0.030 |
Why?
|
| Plasma Substitutes | 1 | 1995 | 2 | 0.030 |
Why?
|
| Phobic Disorders | 1 | 1995 | 65 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1995 | 14 | 0.030 |
Why?
|
| Albumins | 1 | 1995 | 17 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2015 | 99 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 42 | 0.030 |
Why?
|
| Respiratory Mechanics | 2 | 2005 | 6 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 1992 | 34 | 0.030 |
Why?
|
| Reaction Time | 2 | 1996 | 89 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 75 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 1994 | 4 | 0.030 |
Why?
|
| Body Temperature | 2 | 2003 | 41 | 0.030 |
Why?
|
| Axilla | 1 | 2013 | 14 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2013 | 23 | 0.030 |
Why?
|
| Communication | 1 | 2014 | 96 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1990 | 25 | 0.030 |
Why?
|
| Skin Physiological Phenomena | 1 | 1992 | 1 | 0.030 |
Why?
|
| Cardiac Output, Low | 1 | 1992 | 4 | 0.030 |
Why?
|
| Electric Impedance | 1 | 1993 | 24 | 0.030 |
Why?
|
| Aortic Rupture | 1 | 2012 | 3 | 0.030 |
Why?
|
| England | 1 | 2012 | 14 | 0.030 |
Why?
|
| Contraindications | 1 | 2012 | 29 | 0.020 |
Why?
|
| Catheterization | 1 | 1993 | 37 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2012 | 22 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1992 | 59 | 0.020 |
Why?
|
| Patient Care Team | 2 | 1994 | 105 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 1991 | 18 | 0.020 |
Why?
|
| Cisterna Magna | 2 | 2002 | 4 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 177 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2011 | 14 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 5 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 447 | 0.020 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 2011 | 1 | 0.020 |
Why?
|
| Hallucinogens | 1 | 2011 | 2 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2011 | 32 | 0.020 |
Why?
|
| Apgar Score | 1 | 2010 | 1 | 0.020 |
Why?
|
| Berlin | 1 | 2010 | 1 | 0.020 |
Why?
|
| Snoring | 1 | 2010 | 3 | 0.020 |
Why?
|
| Psychomotor Agitation | 1 | 2011 | 12 | 0.020 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2010 | 10 | 0.020 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1990 | 3 | 0.020 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2011 | 129 | 0.020 |
Why?
|
| Verapamil | 1 | 1990 | 21 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 632 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 1990 | 9 | 0.020 |
Why?
|
| Walking | 2 | 2003 | 244 | 0.020 |
Why?
|
| Obstetric Nursing | 1 | 2009 | 1 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2009 | 16 | 0.020 |
Why?
|
| Chronobiology Phenomena | 1 | 2009 | 3 | 0.020 |
Why?
|
| DNA | 1 | 2010 | 97 | 0.020 |
Why?
|
| Narcotics | 1 | 1990 | 34 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2002 | 178 | 0.020 |
Why?
|
| Nursing Staff, Hospital | 1 | 2009 | 25 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 51 | 0.020 |
Why?
|
| Heparin | 3 | 1996 | 21 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 63 | 0.020 |
Why?
|
| Breeding | 1 | 2009 | 1 | 0.020 |
Why?
|
| Parity | 1 | 2009 | 2 | 0.020 |
Why?
|
| Drug Evaluation | 2 | 1988 | 19 | 0.020 |
Why?
|
| Drug Compounding | 1 | 2009 | 3 | 0.020 |
Why?
|
| Syringes | 1 | 2009 | 6 | 0.020 |
Why?
|
| Pharmaceutical Solutions | 1 | 2009 | 2 | 0.020 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1989 | 2 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 113 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 1989 | 12 | 0.020 |
Why?
|
| Anesthesia Department, Hospital | 1 | 1989 | 2 | 0.020 |
Why?
|
| Hospital Departments | 1 | 1989 | 5 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 253 | 0.020 |
Why?
|
| Laser Therapy | 1 | 1989 | 10 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 155 | 0.020 |
Why?
|
| Heart Valves | 1 | 1988 | 2 | 0.020 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2008 | 19 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 1988 | 24 | 0.020 |
Why?
|
| Hemofiltration | 1 | 1988 | 7 | 0.020 |
Why?
|
| Skin | 1 | 1989 | 116 | 0.020 |
Why?
|
| Decompression Sickness | 1 | 1988 | 2 | 0.020 |
Why?
|
| Surgical Equipment | 1 | 2007 | 2 | 0.020 |
Why?
|
| Hindlimb | 1 | 2007 | 15 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2007 | 9 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1987 | 15 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2007 | 30 | 0.020 |
Why?
|
| Spinal Nerve Roots | 1 | 1987 | 13 | 0.020 |
Why?
|
| Lung | 1 | 1988 | 153 | 0.020 |
Why?
|
| Betamethasone | 1 | 2007 | 3 | 0.020 |
Why?
|
| Triamcinolone | 1 | 2007 | 6 | 0.020 |
Why?
|
| Epidural Space | 2 | 2002 | 20 | 0.020 |
Why?
|
| Particle Size | 1 | 2007 | 46 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2007 | 19 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 1986 | 7 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2006 | 17 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2006 | 50 | 0.020 |
Why?
|
| Respiration | 1 | 1986 | 29 | 0.020 |
Why?
|
| Cause of Death | 1 | 2006 | 56 | 0.020 |
Why?
|
| Lumbosacral Region | 1 | 2006 | 51 | 0.020 |
Why?
|
| Vascular Resistance | 2 | 1996 | 12 | 0.020 |
Why?
|
| Sufentanil | 3 | 1990 | 3 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2005 | 73 | 0.020 |
Why?
|
| Hydrocodone | 1 | 2005 | 6 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 244 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2005 | 3 | 0.020 |
Why?
|
| Ibuprofen | 1 | 2005 | 11 | 0.020 |
Why?
|
| Pargyline | 1 | 1985 | 1 | 0.010 |
Why?
|
| Phenelzine | 1 | 1985 | 1 | 0.010 |
Why?
|
| Tranylcypromine | 1 | 1985 | 2 | 0.010 |
Why?
|
| Hydromorphone | 1 | 2005 | 3 | 0.010 |
Why?
|
| Enflurane | 3 | 1990 | 3 | 0.010 |
Why?
|
| Pericardiocentesis | 1 | 2004 | 1 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2004 | 7 | 0.010 |
Why?
|
| Echocardiography | 1 | 2004 | 55 | 0.010 |
Why?
|
| Leg Ulcer | 1 | 2003 | 4 | 0.010 |
Why?
|
| Gangrene | 1 | 2003 | 2 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2003 | 13 | 0.010 |
Why?
|
| Proprioception | 1 | 2003 | 20 | 0.010 |
Why?
|
| Hematocrit | 2 | 1996 | 12 | 0.010 |
Why?
|
| Vibration | 1 | 2003 | 27 | 0.010 |
Why?
|
| Endotoxins | 1 | 2002 | 13 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 2002 | 25 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 2002 | 19 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1988 | 517 | 0.010 |
Why?
|
| Fetal Monitoring | 1 | 2002 | 3 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 21 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2002 | 29 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 23 | 0.010 |
Why?
|
| Intracranial Hypotension | 1 | 2002 | 5 | 0.010 |
Why?
|
| Morbidity | 2 | 1992 | 47 | 0.010 |
Why?
|
| Oximetry | 2 | 1993 | 8 | 0.010 |
Why?
|
| Fibrinolysis | 2 | 1994 | 6 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2002 | 47 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 2004 | 630 | 0.010 |
Why?
|
| United Kingdom | 1 | 2002 | 41 | 0.010 |
Why?
|
| Protamines | 2 | 1994 | 3 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 231 | 0.010 |
Why?
|
| Stroke Volume | 2 | 1995 | 25 | 0.010 |
Why?
|
| Recurrence | 1 | 2002 | 281 | 0.010 |
Why?
|
| Telemetry | 1 | 2000 | 8 | 0.010 |
Why?
|
| Diazepam | 2 | 1990 | 5 | 0.010 |
Why?
|
| Halothane | 2 | 1990 | 10 | 0.010 |
Why?
|
| Surgery, Veterinary | 1 | 1998 | 1 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1998 | 26 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 1998 | 16 | 0.010 |
Why?
|
| Kidney Diseases | 2 | 1990 | 68 | 0.010 |
Why?
|
| Syndrome | 1 | 1998 | 69 | 0.010 |
Why?
|
| Aminocaproates | 1 | 1996 | 1 | 0.010 |
Why?
|
| Erythrocyte Volume | 1 | 1996 | 1 | 0.010 |
Why?
|
| Premedication | 1 | 1996 | 1 | 0.010 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 1996 | 2 | 0.010 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1996 | 2 | 0.010 |
Why?
|
| Transplantation | 1 | 1996 | 4 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 1996 | 6 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 1996 | 10 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1996 | 43 | 0.010 |
Why?
|
| Postoperative Hemorrhage | 1 | 1996 | 20 | 0.010 |
Why?
|
| Drainage | 1 | 1996 | 41 | 0.010 |
Why?
|
| Oropharynx | 1 | 1996 | 2 | 0.010 |
Why?
|
| Mouth | 1 | 1996 | 12 | 0.010 |
Why?
|
| Myocardium | 1 | 1996 | 94 | 0.010 |
Why?
|
| Dioxanes | 1 | 1996 | 2 | 0.010 |
Why?
|
| Glycopyrrolate | 1 | 1996 | 2 | 0.010 |
Why?
|
| Idazoxan | 1 | 1996 | 2 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 4 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1996 | 14 | 0.010 |
Why?
|
| Linear Models | 1 | 1996 | 234 | 0.010 |
Why?
|
| Neoplasms | 1 | 1998 | 213 | 0.010 |
Why?
|
| Wakefulness | 1 | 1996 | 69 | 0.010 |
Why?
|
| Imidazoles | 1 | 1996 | 54 | 0.010 |
Why?
|
| Smoking | 1 | 1996 | 172 | 0.010 |
Why?
|
| Sleep Stages | 1 | 1995 | 19 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1996 | 492 | 0.010 |
Why?
|
| Paralysis | 1 | 1995 | 15 | 0.010 |
Why?
|
| Death | 1 | 1995 | 41 | 0.010 |
Why?
|
| Blood Volume | 1 | 1995 | 1 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1995 | 2 | 0.010 |
Why?
|
| Choice Behavior | 1 | 1995 | 45 | 0.010 |
Why?
|
| Back Pain | 1 | 1995 | 54 | 0.010 |
Why?
|
| Heparin Lyase | 1 | 1994 | 1 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 1994 | 5 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 1994 | 6 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1994 | 28 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1994 | 153 | 0.010 |
Why?
|
| Thermodilution | 1 | 1993 | 5 | 0.010 |
Why?
|
| Knee | 1 | 1993 | 43 | 0.010 |
Why?
|
| Coronary Care Units | 1 | 1992 | 5 | 0.010 |
Why?
|
| Reperfusion | 1 | 1992 | 6 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1992 | 93 | 0.010 |
Why?
|
| Sternum | 1 | 1990 | 3 | 0.010 |
Why?
|
| Anesthesia, Inhalation | 1 | 1990 | 3 | 0.010 |
Why?
|
| Endocarditis | 1 | 1990 | 7 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1992 | 270 | 0.010 |
Why?
|
| Hemostasis | 1 | 1989 | 9 | 0.000 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1989 | 3 | 0.000 |
Why?
|
| Tensile Strength | 1 | 1989 | 23 | 0.000 |
Why?
|
| Hypertension | 1 | 1990 | 169 | 0.000 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1989 | 42 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1989 | 81 | 0.000 |
Why?
|
| Rabbits | 1 | 1989 | 178 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1988 | 10 | 0.000 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 1988 | 1 | 0.000 |
Why?
|
| Veins | 1 | 1988 | 7 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1988 | 32 | 0.000 |
Why?
|
| Subarachnoid Space | 1 | 1987 | 4 | 0.000 |
Why?
|
| Infusion Pumps | 1 | 1987 | 6 | 0.000 |
Why?
|
| Attitude of Health Personnel | 1 | 1989 | 137 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1987 | 30 | 0.000 |
Why?
|
| Whole Blood Coagulation Time | 1 | 1987 | 1 | 0.000 |
Why?
|
| Atracurium | 1 | 1986 | 1 | 0.000 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 1986 | 1 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1988 | 246 | 0.000 |
Why?
|